Soft tissue tumors, such as neurofibromas, also present unique challenges. A case report highlighted a rare instance of diffuse type neurofibroma in the forearm, which is typically found in the ...

Other types include diffuse low-grade gliomas ... more likely to get pLGG if they have one of these genetic diseases: Neurofibromatosis type 1. It causes noncancerous tumors to grow along ...

Abemaciclib is under development for the treatment of Kaposi sarcoma, metastatic gastroesophageal junction adenocarcinoma, neuroblastoma, platinum-resistant ovarian cancer, adenocarcinoma of the ...

It was under development for the treatment of human immunodeficiency virus (HIV) infection and diffuse large B cell lymphoma, chronic myelocytic leukemia, non-Hodgkin lymphoma, multiple myeloma, ...

Pavone discusses how these methods can be used to combat a lack of diversity in clinical trials. While challenges remain, AI is accelerating the process by enabling researchers to identify and design ...

Visit us on Facebook. Opens in a new tab or window Visit us on X. Opens in a new tab or window Visit us on Instagram. Opens in a new tab or window Visit us on LinkedIn. Opens in a new tab or ...

Visit us on Facebook. Opens in a new tab or window Visit us on X. Opens in a new tab or window Visit us on Instagram. Opens in a new tab or window Visit us on LinkedIn. Opens in a new tab or ...

Neurofibroma Market Outlook 2025-2035: The neurofibroma market is demonstrating a promising trajectory, with a projected CAGR of 11.5% across the 7 major markets between 2025 and 2035. A major shift ...

Table 1. 2021 WHO Classification of pLGG/GNTs group, subdivided into three families: pediatric-type diffuse low-grade gliomas, circumscribed astrocytic gliomas, and glioneuronal and neuronal tumors.